Latest News-US TIGER SECURITIES, INC. Mediaroom_Page

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, March 11, 2024 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Comp...

2024-03-12 04:30 1895

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, Feb. 9, 2024 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Compan...

2024-02-10 05:30 4920

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, Jan. 11, 2024 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Compa...

2024-01-12 05:30 4163

Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024

NEW YORK, Dec. 29, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (Nasdaq: DECA) (the "Compa...

2023-12-30 05:30 6835

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, Dec. 11, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Compa...

2023-12-12 05:30 2324

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, Nov. 10, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Compa...

2023-11-11 05:30 4122

Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination

NEW YORK, Oct. 11, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Compa...

2023-10-12 04:30 2850

TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

NEW YORK, Aug. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NAS...

2023-08-19 04:30 5204

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business Combination

NEW YORK, July 13, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" o...

2023-07-13 19:00 4253

Denali Capital Acquisition Corp. Announces Intention to Extend Deadline to Complete an Initial Business Combination

NEW YORK, July 7, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or...

2023-07-08 04:58 5594

TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

NEW YORK, May 19, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASD...

2023-05-20 04:30 5631

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business Combination

NEW YORK, April 12, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" ...

2023-04-13 04:30 3385

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business Combination

NEW YORK, April 6, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" o...

2023-04-07 04:30 4215

Feutune Light Acquisition Corporation Announces Intention to Extend the Deadline for an Initial Business Combination

METUCHEN, N.J., March 20, 2023 /PRNewswire/ -- Feutune Light Acquisition Corporation (NASDAQ: FLFV)...

2023-03-21 04:30 2364

TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

NEW YORK, March 17, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NA...

2023-03-18 04:30 5352

Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas

Initiation of Phase I/II Clinical Trial (Starlight-1) Expected to Occur in Second Half of 2023 EME...

2023-03-09 05:15 1986

Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

* Longevity Biomedical is focused on developing and acquiring new technologies spanning therapeut...

2023-01-26 19:30 3013

TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

NEW YORK, Jan. 20, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NAS...

2023-01-21 05:33 6401

Fortune Rise Acquisition Corporation Confirms to Extend Period to Consummate Initial Business Combination

METUCHEN, N.J., Nov. 1, 2022 /PRNewswire/-- Fortune Rise Acquisition Corporation (NASDAQ: FRLAU) (t...

2022-11-02 05:04 2651

Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp.

NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage b...

2022-10-03 19:27 3447